May 19, 2020 / 5:05 AM / 16 days ago

BRIEF-Bergenbio Q1 Operating Loss Widens To NOK 56.2 Mln

May 19 (Reuters) - Bergenbio ASA:

* : RESULTS FOR THE FIRST QUARTER 2020

* Q1 OPERATING REVENUE NOK 0 MILLION VERSUS NOK 8.7 MILLION YEAR AGO

* Q1 TOTAL OPERATING EXPENSES WERE NOK 56.2 MILLION (NOK 54.5 MILLION)

* Q1 OPERATING LOSS FOR QUARTER CAME TO NOK 56.2 MILLION (NOK 45.8 MILLION)

* IMPACT OF COVID-19 ON OUR CLINICAL TRIALS STARTED TO BECOME VISIBLE TOWARDS END OF Q1 AND ON OUR PRECLINICAL RESEARCH OPERATIONS IN APRIL Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below